2012China Modern MedicineRequires access

Clinical analysis of Fluoxetine hydrochloride in the treatment of post-stroke depression

Lin Yue-jing

Open publisher page 0 citations

Abstract

Objective To observe the clinic efficacy of Fluoxetine on post-stroke depression.Methods One hundred and twenty cases of post-stroke depression patients were randomly divided into the observation group(add with hydrochloric acid prozac) and the control group(conventional treatment) according to the doctor order,each group of 60 cases,the patients in the observation group were administered with Fuoxetine besides conventional way,the control group were treated with conventional way.Then,Hamilton Depression Scale(HAMD),National Institute of Health stroke scale(NIHSS) and Barthel Index(BI) were used to evaluate the curative effect and adverse effects between the two groups.Results After treatment of 8 weeks,Hamilton Depression Rating Scale(HAMD) and Neural Function Defect score(NIHSS) of two groups were significantly decreased(P 0.05 or P 0.01),and the range of decrease in obsevation group was more significant than control group(P 0.01).And there was a marked elevation of Barthel score in the obsevation group compared with the control group(P 0.01).Conclusion Fluoxetine is effective in treatment of post-stroke depression and is prominent on the process of neurofunctional rehabilitation with a little adverse effects.

About this research paper

What this paper is about

Objective To observe the clinic efficacy of Fluoxetine on post-stroke depression.Methods One hundred and twenty cases of post-stroke depression patients were randomly divided into the observation group(add with hydrochloric acid prozac) and the control group(conventional treatment) according to the doctor order,each group of 60 cases,the patients in the observation group were administered with Fuoxetine besides conventional way,the control group were treated with conventional way.Then,Hamilton Depression Scale(HAMD),National Institute of Health stroke scale(NIHSS) and Barthel Index(BI) were used to evaluate the curative effect and adverse effects between the two groups.Results After treatment of 8 weeks,Hamilton Depression Rating Scale(HAMD) and Neural Function Defect score(NIHSS) of two groups were significantly decreased(P 0.05 or P 0.01),and the range of decrease in obsevation group was more significant than control group(P 0.01).And there was a marked elevation of Barthel score in the obsevation group compared with the control group(P 0.01).Conclusion Fluoxetine is effective in treatment of post-stroke depression and is prominent on the process of neurofunctional rehabilitation with a little adverse effects.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To observe the clinic efficacy of Fluoxetine on post-stroke depression.Methods One hundred and twenty cases of post-stroke depression patients were randomly divided into the observation group(add with hydrochloric acid prozac) and the control group(conventional treatment) according to the doctor order,each group of 60 cases,the patients in the observation group were administered with Fuoxetine besides conventional way,the control group were treated with conventional way.Then,Hamilton Depression Scale(HAMD),National Institute of Health stroke scale(NIHSS) and Barthel Index(BI) were used to evaluate the curative effect and adverse effects between the two groups.Results After treatment of 8 weeks,Hamilton Depression Rating Scale(HAMD) and Neural Function Defect score(NIHSS) of two groups were significantly decreased(P 0.05 or P 0.01),and the range of decrease in obsevation group was more significant than control group(P 0.01).And there was a marked elevation of Barthel score in the obsevation group compared with the control group(P 0.01).Conclusion Fluoxetine is effective in treatment of post-stroke depression and is prominent on the process of neurofunctional rehabilitation with a little adverse effects.

Key concepts: Hamd, Medicine, Post-stroke depression, Depression (economics), Fluoxetine, Rating scale, Barthel index, Stroke (engine)

Related papers

Back to paper searchBrowse research topicsOriginal source
Clinical analysis of Fluoxetine hydrochloride in the treatment of post-stroke depression — Research Paper | ScholarLens